Physician profile
Richard Klapchar
NPI 1740238039
$1,802.87
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,425 · 2020: $131 · 2021: $247.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $757.89 | 2019 | |
| Acclarent, INC | $526.86 | 2019-2021 | |
| Intersect Ent, INC. | $179.21 | 2019-2020 | |
| Optinose US, INC. | $110.99 | 2019 | |
| Medtronic USA, INC. | $80.05 | 2020 | |
| Stryker Corporation | $67.85 | 2019 | |
| Axogen | $36.20 | 2019 | |
| Merck Sharp & Dohme LLC | $28.95 | 2019-2020 | |
| Cochlear Americas | $14.87 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Klapchar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.